Who invested in Allyx Therapeutics?
Allyx Therapeutics's investors include National Institutes of Health and Connecticut Innovations.

United States · Series B startup
Funding summaryUpdated 26 Oct 2026
$33Mraised across 3 rounds since 2024, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Source recordedSEC filing: $26M sold
No investor was named in the report.
Filed with the SEC (Form D); no report of this raise yetSEC filing: $3.3M sold, first sale Feb 2026
From Allyx Therapeutics's own website: 1 on the team.
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Allyx Therapeutics's investors include National Institutes of Health and Connecticut Innovations.
Allyx Therapeutics has raised $33M across 3 rounds since 2024.
Allyx Therapeutics's most recent round was a Series B of $27M in May 2026.
Its most recent round, $27M in May 2026, is also its largest on record.
Allyx Therapeutics's first round on record, in Oct 2024, was backed by National Institutes of Health and Connecticut Innovations.
Allyx Therapeutics's latest named round is a Series B, in May 2026.
Allyx Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.